Final Laboratory Report PID :
Name : Mr SUNDARAVDIVELU K Sex/Age : Male / 32 Years Lab ID : 50229603847
Ref. By : DR.PRASHANTH ARUN SRF ID : Ref. ID :
Corporate : M.V.Hospital for Diabetes UHID :
Col Dt. Time : 06-Feb-2025 14:08 Recv Dt. Time : 06-Feb-2025 14:08 Sample Type :
Reg Dt. Time : 06-Feb-2025 14:03 Report Released @ : Report Printed : 06-Feb-2025 19:53
Abnormal Result(s) Summary
Test Name Result Value Unit Reference Range
Bilirubin level Total
Bilirubin Total 2.57 mg/dL 0.2 - 1.2 mg/dL
Bilirubin Indirect 2.12 mg/dL 0.1 - 1
Abnormal Result(s) Summary End
Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh,A-Abnormal)
Page 1 of 4
Final Laboratory Report PID :
Name : Mr SUNDARAVDIVELU K Sex/Age : Male / 32 Years Lab ID : 50229603847
Ref. By : DR.PRASHANTH ARUN SRF ID : Ref. ID :
Corporate : M.V.Hospital for Diabetes UHID :
Col Dt. Time : 06-Feb-2025 14:08 Recv Dt. Time : 06-Feb-2025 14:08 Sample Type : Serum
Reg Dt. Time : 06-Feb-2025 14:03 Report Released @ : 06-Feb-2025 19:51 Report Printed : 06-Feb-2025 19:53
TEST RESULTS UNIT BIOLOGICAL REF RANGE REMARKS
Bilirubin Total H 2.57 mg/dL 0.2 - 1.2 mg/dL
Diazonium Salt
Bilirubin Direct 0.45 mg/dL 0 - 0.5 mg/dL
DIAZO REACTION
Bilirubin Indirect H 2.12 mg/dL 0.1 - 1
Ceruloplasmin 0.23 g/L 0.2 - 0.6
Nephelometry
Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh,A-Abnormal)
JAHABAR Dr.Selvi R
Consultant Biochemist
Verified by Page 2 of 4
MC-5972
Final Laboratory Report PID :
Name : Mr SUNDARAVDIVELU K Sex/Age : Male / 32 Years Lab ID : 50229603847
Ref. By : DR.PRASHANTH ARUN SRF ID : Ref. ID :
Corporate : M.V.Hospital for Diabetes UHID :
Col Dt. Time : 06-Feb-2025 14:08 Recv Dt. Time : 06-Feb-2025 14:08 Sample Type : Serum
Reg Dt. Time : 06-Feb-2025 14:03 Report Released @ : 06-Feb-2025 16:40 Report Printed : 06-Feb-2025 19:53
TEST RESULTS UNIT BIOLOGICAL REF RANGE TEST REMARK
HBsAg
HBsAg, Serum NonReactive S/CO Nonreactive
CMIA
HBsAg OD Value 0.33 S/CO Reactive >=1.0 Non
CMIA
Reactive <1.0
Note :
This is a screening test for detecting HBsAg. All reactive results must be confirmed by Neutralizing confirmatory test or by HBV DNA detection assay.
Discrepant results may be observed during pregnancy, patients receiving mouse monoclonal antibodies for diagnosis or therapy & mutant forms of HBsAg.
For diagnostic purposes, results should be used in conjunction with clinical history and other hepatitis markers for Acute or Chronic infection.Vaccination with
a recombinant HBsAg Hepatitis B vaccine may cause transient positive results. These results are caused by a passive transfer of antigen by vaccination, not
by viral replication. Positive results usually don’t persist for more than 14 days after vaccination, though positive signals up to 52 days have been reported
and may not indicate clinical disease.
Comments :
Hepatitis B Virus (HBV) is a member of the Hepadna virus family causing infections of the liver with extremely variable clinical features. Hepatitis B is
transmitted primarily by blood, body fluids and also spread by sexual transmission and from mother to baby. In most individuals HBV hepatitis is self limiting,
but 1-2% normal adolescents and adults develop Chronic Hepatitis. Frequency of chronic HBV infection is 5-10% in immunocompromised patients and 80%
in neonates. The initial serological marker of acute infection is HBsAg which typically appears 2-3 months after infection and disappears 12-20 weeks after
onset of symptoms. Presistence of HBsAg for more than six months indicates development of carrier state or Chronic liver disease.
Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh,A-Abnormal)
AUTO Dr K Vinodini
MBBS., M.D(Micro)
Verified by Page 3 of 4
MC-5972
Final Laboratory Report PID :
Name : Mr SUNDARAVDIVELU K Sex/Age : Male / 32 Years Lab ID : 50229603847
Ref. By : DR.PRASHANTH ARUN SRF ID : Ref. ID :
Corporate : M.V.Hospital for Diabetes UHID :
Col Dt. Time : 06-Feb-2025 14:08 Recv Dt. Time : 06-Feb-2025 14:08 Sample Type : Serum
Reg Dt. Time : 06-Feb-2025 14:03 Report Released @ : 06-Feb-2025 16:40 Report Printed : 06-Feb-2025 19:53
TEST RESULTS UNIT BIOLOGICAL REF RANGE TEST REMARK
Anti HCV
Anti HCV, Serum NonReactive S/CO Non Reactive
CMIA
Anti HCV OD Value 0.08 S/CO Reactive >=1.0
CMIA
Non Reactive <1.0
Note:
1. This is used for qualitative detection of antibodies to Hepatitis C virus (HCV)in human serum/plasma.
2. It is intended to be used as an aid in the diagnosis of Hepatitis C infection and as a screening test to prevent transmission of Hepatitis C virus (HCV) to
recipients of blood, blood components, cells, tissue and organs.
3. This is screening test. To be used in conjunction with patient history and other hepatitis markers for diagnosis of acute or chronic infection.
4. For heparinized patients, draw specimen prior to heparin therapy as presence of fibrin leads to erroneous results
------------------ End Of Report ------------------
Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh,A-Abnormal)
AUTO Dr K Vinodini
MBBS., M.D(Micro)
Verified by Page 4 of 4
MC-5972
